Cumberland Pharmaceuticals (CPIX) Profit After Tax (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Profit After Tax across 17 years of filings, most recently posting -$3.3 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at -$3.3 million, down 361.49% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.4 million (down 125.5% YoY), and the FY2025 annual result was -$2.9 million, up 55.79% from the prior year.
• Profit After Tax came in at -$3.3 million for Q1 2026 at Cumberland Pharmaceuticals, down from -$1.4 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $1.3 million in Q1 2025 to a low of -$6.3 million in Q4 2023.
• The 5-year median for Profit After Tax is -$1.4 million (2022), against an average of -$1.4 million.
• Across the five-year window, Profit After Tax plunged 1204.25% in 2024 and surged 166.08% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Profit After Tax stood at -$2.5 million in 2022, then plunged by 156.21% to -$6.3 million in 2023, then surged by 69.79% to -$1.9 million in 2024, then gained by 25.85% to -$1.4 million in 2025, then tumbled by 132.84% to -$3.3 million in 2026.
• The last three Profit After Tax figures came in at -$3.3 million (Q1 2026), -$1.4 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.